Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jyotsna Mehta, Edward E. Walsh, Parthiv J. Mahadevia & Ann R. Falsey. (2013) Risk Factors for Respiratory Syncytial Virus Illness Among Patients with Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:3, pages 293-299.
Read now
Read now
Articles from other publishers (19)
Jonathan S. Nguyen-Van-Tam, Maureen O'Leary, Emily T. Martin, Esther Heijnen, Benoit Callendret, Roman Fleischhackl, Christy Comeaux, Thao Mai Phuong Tran & Karin Weber. (2022) Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. European Respiratory Review 31:166, pages 220105.
Crossref
Crossref
Natasha Collinson, Natale Snape, Kenneth Beagley, Emmanuelle Fantino & Kirsten Spann. (2021) COPD Is Associated with Elevated IFN-β Production by Bronchial Epithelial Cells Infected with RSV or hMPV. Viruses 13:5, pages 911.
Crossref
Crossref
Ryan Brown, Sridesh Nath, Alnardo Lora, Ghassan Samaha, Ziyad Elgamal, Ryan Kaiser, Clifford Taggart, Sinéad Weldon & Patrick Geraghty. (2020) Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics. Respiratory Research 21:1.
Crossref
Crossref
Wei Cai, Silke Buda, Ekkehard Schuler, Siddhivinayak Hirve, Wenqing Zhang & Walter Haas. (2020) Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes. Influenza and Other Respiratory Viruses 14:6, pages 658-670.
Crossref
Crossref
María Martín-Vicente, Carolina González-Riaño, Coral Barbas, María Ángeles Jiménez-Sousa, Oscar Brochado-Kith, Salvador Resino & Isidoro Martínez. (2020) Metabolic changes during respiratory syncytial virus infection of epithelial cells. PLOS ONE 15:3, pages e0230844.
Crossref
Crossref
María Martín-Vicente, Rubén González-Sanz, Isabel Cuesta, Sara Monzón, Salvador Resino & Isidoro Martínez. (2020) Downregulation of A20 Expression Increases the Immune Response and Apoptosis and Reduces Virus Production in Cells Infected by the Human Respiratory Syncytial Virus. Vaccines 8:1, pages 100.
Crossref
Crossref
María Martín-Vicente, Salvador Resino & Isidoro Martínez. (2019) siRNA-Mediated Simultaneous Regulation of the Cellular Innate Immune Response and Human Respiratory Syncytial Virus Replication. Biomolecules 9:5, pages 165.
Crossref
Crossref
James M. Walter & Richard G. Wunderink. (2017) Severe Respiratory Viral Infections. Infectious Disease Clinics of North America 31:3, pages 455-474.
Crossref
Crossref
B. David Persson, Aron B. Jaffe, Rachel Fearns & Henry Danahay. (2014) Respiratory Syncytial Virus Can Infect Basal Cells and Alter Human Airway Epithelial Differentiation. PLoS ONE 9:7, pages e102368.
Crossref
Crossref
Clare L. Ross & Trevor T. Hansel. (2014) New Drug Therapies for COPD. Clinics in Chest Medicine 35:1, pages 219-239.
Crossref
Crossref
Manuel Mata, Isidoro Martinez, Jose A. Melero, Herman Tenor & Julio Cortijo. (2013) Roflumilast Inhibits Respiratory Syncytial Virus Infection in Human Differentiated Bronchial Epithelial Cells. PLoS ONE 8:7, pages e69670.
Crossref
Crossref
H. Frickmann, S. Jungblut, T. O. Hirche, U. Groß, M. Kuhns & Andreas Erich Zautner. (2012) The influence of virus infections on the course of COPD. European Journal of Microbiology and Immunology 2:3, pages 176-185.
Crossref
Crossref
G. Dimopoulos, M. Lerikou, S. Tsiodras, Aik Chranioti, E. Perros, U. Anagnostopoulou, A. Armaganidis & P. Karakitsos. (2012) Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics 25:1, pages 12-18.
Crossref
Crossref
Gerardo Arrevillaga, Jorge Gaona, Carla Sánchez, Víctor Rosales & Beatríz Gómez. (2012) Respiratory Syncytial Virus Persistence in Macrophages Downregulates Intercellular Adhesion Molecule-1 Expression and Reduces Adhesion of Non-Typeable <b><i>Haemophilus influenzae</i></b>. Intervirology 55:6, pages 442-450.
Crossref
Crossref
Grigory Ryzhakov, Cheryl Chuk-ke Lai, Katrina Blazek, Ken-win To, Tracy Hussell & Irina Udalova. (2011) IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells. The Journal of Immunology 187:10, pages 5357-5362.
Crossref
Crossref
Manuel Mata, Esteban Morcillo, Concepcion Gimeno & Julio Cortijo. (2011) N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV). Biochemical Pharmacology 82:5, pages 548-555.
Crossref
Crossref
Nicholas A. Meanwell, Christopher W. Cianci & Mark R. Krystal. 2011. Antiviral Drugs. Antiviral Drugs
353
366
.
Sumanta Mukherjee, Dennis M. Lindell, Aaron A. Berlin, Susan B. Morris, Thomas P. Shanley, Marc B. Hershenson & Nicholas W. Lukacs. (2011) IL-17–Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic Disease. The American Journal of Pathology 179:1, pages 248-258.
Crossref
Crossref
Trevor T Hansel & Peter J Barnes. (2009) New drugs for exacerbations of chronic obstructive pulmonary disease. The Lancet 374:9691, pages 744-755.
Crossref
Crossref